Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 51 or older, of any gender, who have been diagnosed with typical Parkinson's disease that does not have a known cause.
- People whose Parkinson's symptoms fall within a mild to moderate range on a standard scale used by doctors (Hoehn & Yahr stages I to III).
- People who feel their memory or thinking skills have been getting worse, or are worse compared to others their age, or who have concerns about their memory or thinking — and who can name at least one everyday thinking or memory challenge they would like help with.
- People whose medications have been stable for at least 4 weeks before joining, with no medication changes planned during the main treatment part of the study.
Who may not be able to join:
- People who have been diagnosed with dementia, or who score below 21 on a standard thinking and memory test called the MoCA.
- People who have another neurological condition, such as a history of stroke or seizures.
- People who have, or have had, a major psychiatric condition such as schizophrenia or bipolar disorder, or who experience symptoms such as hallucinations or delusions, or who have a history of drug abuse. (Note: anxiety and depression related to Parkinson's disease may be acceptable if the trial site determines these would not interfere with participation.)
- People whose circumstances would make it difficult to participate — for example, those who do not speak English, those who are blind, or those who live more than 50 miles from the trial site.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erin R Foster, PhD, OTDR/L, Washington University School of Medicine
Phone: 785-865-8943
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Bangor Goal Setting Interview
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.